351 related articles for article (PubMed ID: 16333838)
1. Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia.
Brunet AS; Ploton C; Galambrun C; Pondarré C; Pages MP; Bleyzac N; Freydière AM; Barbé G; Bertrand Y
Pediatr Blood Cancer; 2006 Nov; 47(6):765-72. PubMed ID: 16333838
[TBL] [Abstract][Full Text] [Related]
2. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine.
Johannsen KH; Handrup MM; Lausen B; Schrøder H; Hasle H
Pediatr Blood Cancer; 2013 Jul; 60(7):1154-60. PubMed ID: 23281248
[TBL] [Abstract][Full Text] [Related]
3. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.
Lehrnbecher T; Varwig D; Kaiser J; Reinhardt D; Klingebiel T; Creutzig U
Leukemia; 2004 Jan; 18(1):72-7. PubMed ID: 14586478
[TBL] [Abstract][Full Text] [Related]
4. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
[TBL] [Abstract][Full Text] [Related]
5. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.
Lewis V; Yanofsky R; Mitchell D; Dix D; Ethier MC; Gillmeister B; Johnston D; Michon B; Stobart K; Portwine C; Silva M; Cellot S; Price V; Bowes L; Zelcer S; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2014 Feb; 33(2):126-9. PubMed ID: 24064558
[TBL] [Abstract][Full Text] [Related]
6. [Bacteremic episodes in pediatric oncologic patients, especially caused by the Streptococcus viridans group].
Berner R; Sauter S; Duffner U; Brandis M; Niemeyer CM
Klin Padiatr; 1998; 210(4):256-60. PubMed ID: 9743962
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of causes of death during intensive chemotherapy according to treatment protocol AML-BFM 93].
Creutzig U; Zimmermann M; Reinhardt D; Lehrnbecher T
Klin Padiatr; 2003; 215(3):151-8. PubMed ID: 12778355
[TBL] [Abstract][Full Text] [Related]
9. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
[TBL] [Abstract][Full Text] [Related]
10. Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
Malagola M; Peli A; Damiani D; Candoni A; Tiribelli M; Martinelli G; Piccaluga PP; Paolini S; De Rosa F; Lauria F; Bocchia M; Gobbi M; Pierri I; Zaccaria A; Zuffa E; Mazza P; Priccolo G; Gugliotta L; Bonini A; Visani G; Skert C; Bergonzi C; Roccaro AM; Filì C; Fanin R; Baccarani M; Russo D
Eur J Haematol; 2008 Nov; 81(5):354-63. PubMed ID: 18637030
[TBL] [Abstract][Full Text] [Related]
11. Infections with viridans group streptococci in children with cancer.
Reilly AF; Lange BJ
Pediatr Blood Cancer; 2007 Nov; 49(6):774-80. PubMed ID: 17588233
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
[TBL] [Abstract][Full Text] [Related]
13. Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia.
Okamoto Y; Ribeiro RC; Srivastava DK; Shenep JL; Pui CH; Razzouk BI
J Pediatr Hematol Oncol; 2003 Sep; 25(9):696-703. PubMed ID: 12972804
[TBL] [Abstract][Full Text] [Related]
14. Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia.
Graubner UB; Porzig S; Jorch N; Kolb R; Wessalowski R; Escherich G; Janka GE
Pediatr Blood Cancer; 2008 Feb; 50(2):259-63. PubMed ID: 17635005
[TBL] [Abstract][Full Text] [Related]
15. Trends in infections in children with malignant disease in 2000: comparison of data of 1980/81.
Laws HJ; Schneider DT; Janssen G; Wessalowski R; Dilloo D; Meisel R; Adams O; Mackenzie C; Göbel U
Pediatr Hematol Oncol; 2007; 24(5):343-54. PubMed ID: 17613879
[TBL] [Abstract][Full Text] [Related]
16. [Consolidation of therapy of acute myeloid leukemia with the AML-BFM 93 protocol in children in the Czech Republic].
Starý J; Gajdos P; Blazek B; Ptoszková H; Hrstková H; Kopecná L; Tousovská K; Hak J; Procházková D; Cerná Z; Jabali Y; Timr P; Vávra V; Sedlácek P; Smísek P; Hrusák O; Michalová K
Cas Lek Cesk; 2004; 143(4):257-63. PubMed ID: 15218726
[TBL] [Abstract][Full Text] [Related]
17. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
[TBL] [Abstract][Full Text] [Related]
18. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population.
Rozkiewicz D; Daniluk T; Sciepuk M; Zaremba ML; Cylwik-Rokicka D; Luczaj-Cepowicz E; Milewska R; Marczuk-Kolada G; Stokowska W
Adv Med Sci; 2006; 51 Suppl 1():191-5. PubMed ID: 17460837
[TBL] [Abstract][Full Text] [Related]
19. Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimen.
Girmenia C; Lo Coco F; Breccia M; Latagliata R; Spadea A; D'Andrea M; Gentile G; Micozzi A; Alimena G; Martino P; Mandelli F
Leukemia; 2003 May; 17(5):925-30. PubMed ID: 12750707
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors for invasive fungal infections during intensive chemotherapy of acute leukemia--retrospective study].
Zupanić-Krmek D; Nemet D; Mrsić M; Bogdanić V; Labar B; Jandrlić M; Kalenić S
Acta Med Croatica; 2004; 58(4):275-84. PubMed ID: 15700683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
